Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.21
Delayed Data
As of Aug 28
 +0.15 / +14.15%
Today’s Change
0.84
Today|||52-Week Range
8.23
-52.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash9.3M14.9M15.1M22.2M
 
 
 
 
 
Short Term Investment Cash-4.9M5.6M181.0K7.1M
 
 
 
 
 
Cash & Short Term Investments44.1M71.2M39.3M43.0M
 
 
 
 
 
 
ReceivablesReceivables0.000.00------
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets1.6M1.7M1.2M1.2M
 
 
 
 
 
Current Assets45.7M72.9M40.5M44.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.3M--23.0K42.0K
 
 
 
 
Depreciation-1.3M------
 
 
Other Assets130.0K42.0K10.0K0.00
 
 
 
 
Total Assets45.9M73.0M40.5M44.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable658.0K78.0K953.0K0.00
 
 
 
 
Short Term Debt0.006.6M9.0M9.3M
 
 
 
 
Accrued Expenses4.2M7.6M6.4M6.2M
 
 
 
 
 
Other Current Liabilities6.5M23.6M22.3M16.3M
 
 
 
 
 
Other Liabilities8.4M31.7M34.0M27.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.5M17.7M9.0M0.00
 
 
 
 
Total Liabilities17.8M61.1M46.7M30.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity28.0M12.0M-6.2M13.8M
 
 
 
 
 
Total Shareholder Equity28.0M12.0M-6.2M13.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding46.8M51.6M54.3M66.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.